What is an Evidence Summary?
Key messages from scientific research that's ready to be acted on
Got It, Hide this
Short-wave therapy reduces pain related to knee osteoarthritis in the short term but does not improve physical function
Wang H, Zhang C, Gao C, et al. Effects of short-wave therapy in patients with knee osteoarthritis: A systematic review and meta-analysis. Clin Rehabil. 2017;31:660-71.
In people who have knee osteoarthritis, does short-wave therapy reduce pain or improve physical function?
Osteoarthritis is a disease of the joints and often occurs in knees. It develops when your joints lose the cartilage that protects the ends of your bones. Symptoms of knee osteoarthritis include pain, tenderness, joint stiffness, and worsening physical functioning. There is no cure, and it often gets worse over time.
There are various treatments for the symptoms of knee osteoarthritis. This review is about short-wave therapy. Short-wave therapy uses electromagnetic radiation and is noninvasive. It can be delivered in a continuous wave or pulsed wave form.
How the review was done
The researchers did a systematic review, searching for studies that were published up to October 2016. They found 8 randomized controlled trials with 542 people who were 42 to 85 years of age (mostly women).
The key features of the trials were:
- people had knee osteoarthritis;
- treatment was short-wave therapy, alone or combined with either routine care or exercise (with or without education or hot packs);
- short-wave therapy was mostly compared with placebo (a short-wave therapy device that was not powered to provide radiation) and sometimes compared with treatment other than short-wave therapy (mainly exercise or routine care); and
- most people were treated for 3 weeks (range 2 to 8 weeks) over 6 to 24 sessions.
What the researchers found
Compared with placebo or no short-wave therapy, short-wave therapy:
- reduced pain at the end of treatment but not after up to 12 months of follow-up;
- improved extensor muscle strength at the end of treatment; and
- did not change physical function, knee stiffness, or flexor muscle strength.
In people with knee osteoarthritis, short-wave therapy reduces pain at the end of treatment but does not improve physical function.
Short-wave therapy vs control* in people with knee osteoarthritis
6 trials (326 people)
Reduced pain at end of treatment.
3 trials (147 people)
No effect on pain at up to 3 months of follow-up.
2 trials (143 people)
No effect on pain at 6 to 12 months of follow-up.
6 trials (377 people)
No effect on physical function at end of treatment.
4 trials (310 people)
No effect on physical function at up to 3 months of follow-up.
3 trials (247 people)
No effect on knee stiffness at end of treatment or at up to 3 months of follow-up.
2 trials (80 people)
Improved extensor muscle strength but not flexor muscle strength at end of treatment.
A harmless, inactive, and simulated treatment.
Randomized controlled trials
Studies where people are assigned to one of the treatments purely by chance.
A comprehensive evaluation of the available research evidence on a particular topic.
Related Evidence Summaries
Cochrane Database Syst Rev (2019)
Journal of Medical Internet Research (2018)
Cochrane Database Syst Rev (2017)
Related Web Resources
This patient decision aid helps adults with rheumatoid arthritis decide on whether or not to take tocilizumab (Actemra®) by comparing the benefits and side effects of both options.
This patient decision aid helps people with osteoarthritis decide on whether or not to have transcutaneous electrostimulation by comparing the benefits and side effects of both options.
This patient decision aid helps adults with rheumatoid arthritis decide on whether to take methotrexate (Rheumatrex®) alone or with other disease modifying anti-rheumatic drugs by comparing the benefits and side effects of both options.
DISCLAIMER These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal